Pilz L - Search Results

1

Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.

Buchholz E, Manegold C, Pilz L, Thatcher N, Drings P. Buchholz E, et al. Among authors: pilz l. J Thorac Oncol. 2007 Jan;2(1):51-8. doi: 10.1097/JTO.0b013e31802baf9d. J Thorac Oncol. 2007. PMID: 17410010 Free article. Clinical Trial.

2

Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer.

Manegold C, Pilz LR, Koschel G, Romer KS, Mezger J, Hruska D, Dornof W, Gosse H, Gatzemeier U. Manegold C, et al. Clin Lung Cancer. 2005 Nov;7(3):208-14. doi: 10.3816/clc.2005.n.038. Clin Lung Cancer. 2005. PMID: 16354317 Clinical Trial.

3

Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer.

Manegold C, Koschel G, Hruska D, Scott-von-Römer K, Mezger J, Pilz LR. Manegold C, et al. Clin Lung Cancer. 2007 Jan;8(4):245-51. doi: 10.3816/clc.2007.n.001. Clin Lung Cancer. 2007. PMID: 17311688 Clinical Trial.

4

Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.

Nikolova DA, Asangani IA, Nelson LD, Hughes DP, Siwak DR, Mills GB, Harms A, Buchholz E, Pilz LR, Manegold C, Allgayer H. Nikolova DA, et al. Cancer Res. 2009 Mar 15;69(6):2461-70. doi: 10.1158/0008-5472.CAN-08-3236. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276367

5

Pemetrexed for the treatment of non-small-cell lung cancer.

Manegold C, Schmid-Bindert G, Pilz LR. Manegold C, et al. Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97. Expert Rev Anticancer Ther. 2009. PMID: 19761423 Review.

6

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer.

Hotta K, Suzuki E, Di Maio M, Chiodini P, Fujiwara Y, Takigawa N, Ichihara E, Reck M, Manegold C, Pilz L, Hisamoto-Sato A, Tabata M, Tanimoto M, Shepherd FA, Kiura K. Hotta K, et al. Among authors: pilz l. Lung Cancer. 2013 Jan;79(1):20-6. doi: 10.1016/j.lungcan.2012.10.007. Epub 2012 Nov 17. Lung Cancer. 2013. PMID: 23164554 Review.

7

Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC).

Schrimpf D, Manegold C, Pilz LR. Schrimpf D, et al. Int J Clin Pharmacol Ther. 2013 Jan;51(1):84-6. doi: 10.5414/cpp51084. Int J Clin Pharmacol Ther. 2013. PMID: 23260009 Free article. No abstract available.

8

Dynamic volume perfusion computed tomography parameters versus RECIST for the prediction of outcome in lung cancer patients treated with conventional chemotherapy.

Sudarski S, Shi J, Schmid-Bindert G, Manegold C, Pilz LR, Zhou C, Schoenberg SO, Henzler T. Sudarski S, et al. J Thorac Oncol. 2015 Jan;10(1):164-71. doi: 10.1097/JTO.0000000000000376. J Thorac Oncol. 2015. PMID: 25247342 Free article. Clinical Trial.

9

Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop.

Henzler T, Goldstraw P, Wenz F, Pirker R, Weder W, Apfaltrer P, Meyer M, Buesing K, Crino L, Fennell D, Fink C, Grunenwald D, Manegold C, Pilz L, Schoenberg SO, Suresh S, Vansteenkiste J, Voigt W, Wängler B, Schmid-Bindert G. Henzler T, et al. Among authors: pilz l. J Thorac Oncol. 2015 Feb;10(2):237-49. doi: 10.1097/JTO.0000000000000412. J Thorac Oncol. 2015. PMID: 25611226 Free article.

10

Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?

Pilz LR, Manegold C, Schmid-Bindert G. Pilz LR, et al. Transl Lung Cancer Res. 2012 Mar;1(1):26-35. doi: 10.3978/j.issn.2218-6751.2011.12.08. Transl Lung Cancer Res. 2012. PMID: 25806152 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters